目前商业化的是炎症药物Dextenza,今年YoY估计有25%;
2024Q1,青光眼的 OTX-TIC phase2 data readout;
2024Q2,Non-proliferative diabetic retinopathy的phase1 data readout。
截止Q3,公司还有现金1.03亿美元,催化剂集...查看全文
牛唐2023-12-15 22:18
医药板块速评(2023.12.13)
1、$Apellis制药(APLS)$ 大跌,是否有抄底机会?
2、$Ocular Therapeutix(OCUL)$ 增发,后续走势如何看?
3、 $拼多多(PDD)、$Nu Holdings(NU)、$辉瑞(PFE)、$美国银行(BAC)、$Snowflake(SNOW)$ 期权大量成交,是否有跟仓机会?查看全文
产业链观察2023-11-01 22:27
#药闻简讯# 2023年11月1日,专注于眼部疾病和病症创新疗法的配方、开发和商业化的生物制药公司$Ocular Therapeutix(OCUL)$ ,今天宣布已收到美国食品和药物管理局(FDA)关于公司正在进行的AXPAXLI(阿昔替尼)关键性3期临床试验(SPA)的特别协议评估(SPA)的书面协议玻璃体内植入物),用于治疗...查看全文
产业链观察2023-10-04 05:26
#药闻简讯# 2023 年 10 月 03 日,$Ocular Therapeutix(OCUL)$ 今天宣布启动其首个关键性临床试验,评估公司的阿西替尼玻璃体内植入物 OTX-TKI,用于治疗湿性年龄相关性黄斑变性(湿性 AMD)。OTX-TKI还被开发用于治疗糖尿病视网膜病变和其他视网膜疾病。
Ocular Therapeutix 公司已就该试验的...查看全文
牛唐2023-06-16 17:08
医药板块速评(2022.06.15)
1、美国债务上限问题解决,美债后续走势如何看?
2、$Ocular Therapeutix(OCUL)暴跌,是否有抄底机会?
3、$C3.ai(AI)$ 、$Sonnet(SONN) 、$The Trade Desk(TTD)$ 、$星巴克(SBUX)$ 、$波音(BA)、$味好美(MKC)期权异动,后续走势如何看?查看全文
Ocular Therapeutix(OCUL)2023-02-13 19:18
$Ocular Therapeutix(OCUL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-23-004374 Act: 34 Size: 88 KB 网页链接查看全文
Ocular Therapeutix(OCUL)03-26 04:45
$Ocular Therapeutix(OCUL)$ S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers Accession Number: 0001104659-24-038470 Act: 33 Size: 380 KB 网页链接查看全文
Ocular Therapeutix(OCUL)03-12 04:15
$Ocular Therapeutix(OCUL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-002902 Act: 34 Size: 12 MB 网页链接查看全文
$Ocular Therapeutix(OCUL)$ S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers Accession Number: 0001104659-24-038470 Act: 33 Size: 380 KB 网页链接
$Ocular Therapeutix(OCUL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-032992 Act: 33 Size: 87 KB 网页链接
$Ocular Therapeutix(OCUL)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-032974 Act: 34 Size: 295 KB 网页链接
$Ocular Therapeutix(OCUL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-002902 Act: 34 Size: 12 MB 网页链接
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000893838-24-000022 Size: 7 KB 网页链接
$Ocular Therapeutix(OCUL)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001140361-24-009774 Act: 34 Size: 65 KB 网页链接
$Ocular Therapeutix(OCUL)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-24-027719 Size: 11 KB 网页链接
$Ocular Therapeutix(OCUL)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-24-027722 Size: 11 KB 网页链接
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-027726 Size: 7 KB 网页链接
$Ocular Therapeutix(OCUL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-027724 Size: 7 KB 网页链接